MX394631B - Protecciones contra fallas de control a intervalo. - Google Patents
Protecciones contra fallas de control a intervalo.Info
- Publication number
- MX394631B MX394631B MX2018014683A MX2018014683A MX394631B MX 394631 B MX394631 B MX 394631B MX 2018014683 A MX2018014683 A MX 2018014683A MX 2018014683 A MX2018014683 A MX 2018014683A MX 394631 B MX394631 B MX 394631B
- Authority
- MX
- Mexico
- Prior art keywords
- glucose
- person
- computing device
- rate
- diabetes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
- A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic
- A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic using feedback of body parameters, e.g. blood sugar or pressure
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M2005/14208—Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M2005/14288—Infusion or injection simulation
- A61M2005/14292—Computer-based infusion planning or simulation of spatio-temporal infusate distribution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3303—Using a biosensor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/20—Blood composition characteristics
- A61M2230/201—Glucose concentration
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Pathology (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Anesthesiology (AREA)
- Biophysics (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Surgery (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Databases & Information Systems (AREA)
- Data Mining & Analysis (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Emergency Medicine (AREA)
- Diabetes (AREA)
- Business, Economics & Management (AREA)
- General Business, Economics & Management (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Train Traffic Observation, Control, And Security (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Control Of Motors That Do Not Use Commutators (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Valve Device For Special Equipments (AREA)
Abstract
Se describen métodos y sistemas para determinar un ajuste de tasa basal de insulina en un sistema de monitoreo continuo de glucosa de una persona con diabetes. Un método puede incluir recibir, por el al menos un dispositivo de cómputo, una señal representativa de al menos una medición de glucosa y detectar, por el al menos un dispositivo de cómputo, un estado de glucosa de la persona en función de la señal, el estado de glucosa detectado incluyendo un nivel de glucosa de la persona y una tasa de cambio del nivel de glucosa. El método también puede incluir el cálculo, por el al menos un dispositivo de cómputo, de un ajuste a una tasa basal de un dispositivo de administración de terapia con base en un algoritmo de control a intervalo y al menos una restricción de protección contra fallas para compensar los cambios en la sensibilidad a insulina de la persona con diabetes o medición de glucosa inexacta.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/170,425 US10332632B2 (en) | 2016-06-01 | 2016-06-01 | Control-to-range failsafes |
| PCT/US2017/031662 WO2017209903A1 (en) | 2016-06-01 | 2017-05-09 | Control-to-range failsafes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2018014683A MX2018014683A (es) | 2019-02-28 |
| MX394631B true MX394631B (es) | 2025-03-24 |
Family
ID=58745387
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018014683A MX394631B (es) | 2016-06-01 | 2017-05-09 | Protecciones contra fallas de control a intervalo. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10332632B2 (es) |
| EP (1) | EP3479262B1 (es) |
| KR (1) | KR102432415B1 (es) |
| CN (1) | CN109478422B (es) |
| AU (1) | AU2017275393B2 (es) |
| CA (1) | CA3025902C (es) |
| ES (1) | ES2939640T3 (es) |
| FI (1) | FI3479262T3 (es) |
| HU (1) | HUE061267T2 (es) |
| MX (1) | MX394631B (es) |
| WO (1) | WO2017209903A1 (es) |
Families Citing this family (76)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8417311B2 (en) | 2008-09-12 | 2013-04-09 | Optiscan Biomedical Corporation | Fluid component analysis system and method for glucose monitoring and control |
| US7972296B2 (en) | 2007-10-10 | 2011-07-05 | Optiscan Biomedical Corporation | Fluid component analysis system and method for glucose monitoring and control |
| US7959598B2 (en) | 2008-08-20 | 2011-06-14 | Asante Solutions, Inc. | Infusion pump systems and methods |
| WO2014172467A1 (en) | 2013-04-16 | 2014-10-23 | Smartloop Llc | Discretionary insulin delivery systems and methods |
| US9561324B2 (en) | 2013-07-19 | 2017-02-07 | Bigfoot Biomedical, Inc. | Infusion pump system and method |
| GB2523989B (en) | 2014-01-30 | 2020-07-29 | Insulet Netherlands B V | Therapeutic product delivery system and method of pairing |
| US9465917B2 (en) * | 2014-05-30 | 2016-10-11 | Roche Diabetes Care, Inc. | Hazard based assessment patterns |
| CA2977053C (en) | 2015-02-18 | 2023-08-01 | Insulet Corporation | Fluid delivery and infusion devices, and methods of use thereof |
| EP3374905A1 (en) | 2016-01-13 | 2018-09-19 | Bigfoot Biomedical, Inc. | User interface for diabetes management system |
| HK1256995A1 (zh) | 2016-01-14 | 2019-10-11 | Bigfoot Biomedical, Inc. | 药物输送设备、系统和方法中的阻塞解决方案 |
| EP4545005A3 (en) | 2016-01-14 | 2025-07-02 | Insulet Corporation | Adjusting insulin delivery rates |
| US12383166B2 (en) | 2016-05-23 | 2025-08-12 | Insulet Corporation | Insulin delivery system and methods with risk-based set points |
| KR102448156B1 (ko) | 2016-08-30 | 2022-09-29 | 에네오스 가부시키가이샤 | 올리고머의 제조 방법 및 촉매 |
| WO2018058041A1 (en) | 2016-09-23 | 2018-03-29 | Insulet Corporation | Fluid delivery device with sensor |
| AU2017376111B2 (en) | 2016-12-12 | 2023-02-02 | Bigfoot Biomedical, Inc. | Alarms and alerts for medication delivery devices and related systems and methods |
| US10500334B2 (en) | 2017-01-13 | 2019-12-10 | Bigfoot Biomedical, Inc. | System and method for adjusting insulin delivery |
| EP4708310A3 (en) | 2017-01-13 | 2026-05-06 | Insulet Corporation | Insulin delivery methods, systems and devices |
| US10758675B2 (en) | 2017-01-13 | 2020-09-01 | Bigfoot Biomedical, Inc. | System and method for adjusting insulin delivery |
| US10583250B2 (en) | 2017-01-13 | 2020-03-10 | Bigfoot Biomedical, Inc. | System and method for adjusting insulin delivery |
| EP4708311A3 (en) | 2017-01-13 | 2026-05-20 | Insulet Corporation | METHODS, SYSTEMS AND DEVICES FOR INSULIN ADMINISTRATION |
| US10881793B2 (en) | 2017-01-13 | 2021-01-05 | Bigfoot Biomedical, Inc. | System and method for adjusting insulin delivery |
| CA3059985C (en) | 2017-05-05 | 2023-08-08 | Eli Lilly And Company | Closed loop control of physiological glucose |
| US12653426B2 (en) | 2017-07-13 | 2026-06-16 | Bigfoot Biomedical, Inc. | Multi-scale display of blood glucose information |
| EP4765154A2 (en) | 2017-08-02 | 2026-06-24 | Diabeloop | Closed-loop blood glucose control systems and methods |
| JP7133625B2 (ja) | 2017-12-21 | 2022-09-08 | イーライ リリー アンド カンパニー | 生理的グルコースの閉ループ制御 |
| US10818390B1 (en) * | 2017-12-27 | 2020-10-27 | Verily Life Sciences Llc | Pattern discovery in continuous glucose monitoring data |
| USD928199S1 (en) | 2018-04-02 | 2021-08-17 | Bigfoot Biomedical, Inc. | Medication delivery device with icons |
| US11565043B2 (en) | 2018-05-04 | 2023-01-31 | Insulet Corporation | Safety constraints for a control algorithm based drug delivery system |
| US12562251B1 (en) | 2018-05-09 | 2026-02-24 | Bigfoot Biomedical, Inc. | Computing architecture for assuring the provenance of medication therapy related parameters, and related systems, methods and devices |
| CN112313754A (zh) | 2018-06-22 | 2021-02-02 | 伊莱利利公司 | 胰岛素和普兰林肽输送系统、方法和设备 |
| AU2019347755B2 (en) | 2018-09-28 | 2023-02-02 | Insulet Corporation | Activity mode for artificial pancreas system |
| WO2020077223A1 (en) | 2018-10-11 | 2020-04-16 | Insulet Corporation | Event detection for drug delivery system |
| USD920343S1 (en) | 2019-01-09 | 2021-05-25 | Bigfoot Biomedical, Inc. | Display screen or portion thereof with graphical user interface associated with insulin delivery |
| US11801344B2 (en) * | 2019-09-13 | 2023-10-31 | Insulet Corporation | Blood glucose rate of change modulation of meal and correction insulin bolus quantity |
| US11935637B2 (en) | 2019-09-27 | 2024-03-19 | Insulet Corporation | Onboarding and total daily insulin adaptivity |
| EP4354455B1 (en) | 2019-12-06 | 2025-10-29 | Insulet Corporation | Techniques and devices providing adaptivity and personalization in diabetes treatment |
| US11833329B2 (en) | 2019-12-20 | 2023-12-05 | Insulet Corporation | Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns |
| WO2021141941A1 (en) | 2020-01-06 | 2021-07-15 | Insulet Corporation | Prediction of meal and/or exercise events based on persistent residuals |
| WO2021158580A1 (en) | 2020-02-03 | 2021-08-12 | Insulet Corporation | Use of fuzzy logic in predicting user behavior affecting blood glucose concentration |
| US11551802B2 (en) | 2020-02-11 | 2023-01-10 | Insulet Corporation | Early meal detection and calorie intake detection |
| US11986630B2 (en) | 2020-02-12 | 2024-05-21 | Insulet Corporation | Dual hormone delivery system for reducing impending hypoglycemia and/or hyperglycemia risk |
| US11547800B2 (en) | 2020-02-12 | 2023-01-10 | Insulet Corporation | User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system |
| US11324889B2 (en) | 2020-02-14 | 2022-05-10 | Insulet Corporation | Compensation for missing readings from a glucose monitor in an automated insulin delivery system |
| US12495994B2 (en) | 2020-02-20 | 2025-12-16 | Insulet Corporation | Meal bolus subcategories in model based insulin therapy |
| US11607493B2 (en) | 2020-04-06 | 2023-03-21 | Insulet Corporation | Initial total daily insulin setting for user onboarding |
| US12121700B2 (en) | 2020-07-22 | 2024-10-22 | Insulet Corporation | Open-loop insulin delivery basal parameters based on insulin delivery records |
| US11684716B2 (en) | 2020-07-31 | 2023-06-27 | Insulet Corporation | Techniques to reduce risk of occlusions in drug delivery systems |
| US12569619B2 (en) | 2020-09-21 | 2026-03-10 | Insulet Corporation | Techniques for determining automated insulin delivery dosages |
| US12115351B2 (en) | 2020-09-30 | 2024-10-15 | Insulet Corporation | Secure wireless communications between a glucose monitor and other devices |
| EP4696344A3 (en) | 2020-09-30 | 2026-04-15 | Insulet Corporation | Drug delivery device with integrated optical-based glucose monitor |
| WO2022165518A1 (en) * | 2021-01-28 | 2022-08-04 | Tandem Diabetes Care, Inc. | Systems and methods for automated insulin delivery for diabetes therapy |
| EP4285376A1 (en) | 2021-01-29 | 2023-12-06 | Insulet Corporation | Techniques and devices that adapt basal profiles for drug delivery applications |
| US11160925B1 (en) | 2021-01-29 | 2021-11-02 | Insulet Corporation | Automatic drug delivery system for delivery of a GLP-1 therapeutic |
| US20220249773A1 (en) * | 2021-02-05 | 2022-08-11 | Insulet Corporation | Techniques and devices for adaptation of maximum drug delivery limits |
| US12636435B2 (en) | 2021-02-26 | 2026-05-26 | Insulet Corporation | Techniques for optimizing usage of an automatic drug delivery system |
| US11904140B2 (en) | 2021-03-10 | 2024-02-20 | Insulet Corporation | Adaptable asymmetric medicament cost component in a control system for medicament delivery |
| WO2022192482A1 (en) | 2021-03-10 | 2022-09-15 | Insulet Corporation | A medicament delivery device with an adjustable and piecewise analyte level cost component to address persistent positive analyte level excursions |
| US12592306B2 (en) | 2021-04-28 | 2026-03-31 | Insulet Corporation | Devices and methods for initialization of drug delivery devices using measured analyte sensor information |
| US12496398B2 (en) | 2021-05-28 | 2025-12-16 | Insulet Corporation | Threshold based automatic glucose control response |
| EP4101482A1 (en) | 2021-06-07 | 2022-12-14 | Insulet Corporation | Exercise safety prediction based on physiological conditions |
| US20220395638A1 (en) * | 2021-06-14 | 2022-12-15 | Insulet Corporation | Method for modification of maximum delivery limits in automatic drug delivery systems |
| US12514980B2 (en) | 2021-06-30 | 2026-01-06 | Insulet Corporation | Adjustment of medicament delivery by a medicament delivery device based on menstrual cycle phase |
| US12521486B2 (en) | 2021-07-16 | 2026-01-13 | Insulet Corporation | Method for modification of insulin delivery during pregnancy in automatic insulin delivery systems |
| US12653949B2 (en) | 2021-07-29 | 2026-06-16 | Insulet Corporation | Adaptation of medicament delivery in response to user stress load |
| EP4409581A1 (en) | 2021-09-27 | 2024-08-07 | Insulet Corporation | Techniques enabling adaptation of parameters in aid systems by user input |
| WO2023102010A1 (en) * | 2021-11-30 | 2023-06-08 | Tandem Diabetes Care, Inc. | System and method of modifying user profile in automated insulin delivery |
| WO2023102114A1 (en) * | 2021-12-01 | 2023-06-08 | Insulet Corporation | Optimizing embedded formulations for drug delivery |
| US11439754B1 (en) | 2021-12-01 | 2022-09-13 | Insulet Corporation | Optimizing embedded formulations for drug delivery |
| WO2023150737A1 (en) | 2022-02-07 | 2023-08-10 | Insulet Corporation | Techniques for determining medication correction factors in automatic medication delivery systems |
| EP4243030A1 (en) | 2022-03-09 | 2023-09-13 | Insulet Corporation | Adjusting medicament delivery parameters in an open loop medicament delivery mode |
| EP4511843A1 (en) | 2022-04-21 | 2025-02-26 | Insulet Corporation | Insulin adaptation and safety monitoring for sick day management |
| WO2023212007A1 (en) | 2022-04-26 | 2023-11-02 | Dexcom, Inc. | System and method for titrating basal insulin doses |
| CN117370995A (zh) * | 2022-06-29 | 2024-01-09 | 上海联影智融医疗科技有限公司 | 胰岛素设备控制方法、装置、系统和计算机设备 |
| KR20250129777A (ko) | 2023-01-06 | 2025-08-29 | 인슐렛 코포레이션 | 후속 자동 안전 제약 완화를 갖는 자동으로 또는 수동으로 개시되는 음식 볼러스 전달 |
| US20250032710A1 (en) * | 2023-07-25 | 2025-01-30 | Dexcom, Inc. | Timing and dosing improvements for diabetes management |
| FR3167866A1 (fr) * | 2024-10-24 | 2026-05-01 | Diabeloop | Gestion de l'administration d'insuline dans les systèmes en boucle fermée |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8974386B2 (en) * | 1998-04-30 | 2015-03-10 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US8882666B1 (en) * | 1998-05-08 | 2014-11-11 | Ideal Life Inc. | Personal health monitoring and/or communication system |
| US7395158B2 (en) | 2000-05-30 | 2008-07-01 | Sensys Medical, Inc. | Method of screening for disorders of glucose metabolism |
| ES2304394T3 (es) | 2000-08-18 | 2008-10-16 | Animas Technologies Llc | Dispositivo para la prediccion de eventos hipoglucemicos. |
| AU2001291189A1 (en) | 2000-09-22 | 2002-04-02 | Knobbe, Lim And Buckingham | Method and apparatus for real-time estimation and control of pysiological parameters |
| US9247901B2 (en) | 2003-08-22 | 2016-02-02 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
| US7278983B2 (en) | 2002-07-24 | 2007-10-09 | Medtronic Minimed, Inc. | Physiological monitoring device for controlling a medication infusion device |
| US7291107B2 (en) | 2004-08-26 | 2007-11-06 | Roche Diagnostics Operations, Inc. | Insulin bolus recommendation system |
| US8684922B2 (en) | 2006-05-12 | 2014-04-01 | Bao Tran | Health monitoring system |
| US20080269714A1 (en) | 2007-04-25 | 2008-10-30 | Medtronic Minimed, Inc. | Closed loop/semi-closed loop therapy modification system |
| EP2164387A4 (en) * | 2007-07-09 | 2011-09-07 | Univ Virginia Patent Found | METHOD, SYSTEM AND COMPUTER PROGRAM PRODUCT FOR THE ASSESSMENT OF INSULIN SENSITIVITY, INSULIN / GLUCOSE RATIO AND INSULIN CORRECTION FACTORS IN DIABETES FROM SELF-MONITORING DATA |
| GB0719969D0 (en) | 2007-10-12 | 2007-11-21 | Cambridge Entpr Ltd | Substance monitoring and control in human or animal bodies |
| US7731659B2 (en) | 2007-10-18 | 2010-06-08 | Lifescan Scotland Limited | Method for predicting a user's future glycemic state |
| US20100262434A1 (en) | 2007-12-13 | 2010-10-14 | Shaya Steven A | Method and apparatus to calculate diabetic sensitivity factors affecting blood glucose |
| US8734422B2 (en) | 2008-08-31 | 2014-05-27 | Abbott Diabetes Care Inc. | Closed loop control with improved alarm functions |
| GB2466183A (en) | 2008-12-09 | 2010-06-16 | Cambridge Entpr Ltd | Closed loop diabetes management system |
| US20120123234A1 (en) * | 2009-02-26 | 2012-05-17 | Eran Atlas | Method and system for automatic monitoring of diabetes related treatments |
| EP2433235A2 (en) | 2009-05-22 | 2012-03-28 | Abbott Diabetes Care, Inc. | Safety features for integrated insulin delivery system |
| US20110071464A1 (en) | 2009-09-23 | 2011-03-24 | Medtronic Minimed, Inc. | Semi-closed loop insulin delivery |
| US8843321B2 (en) | 2010-01-26 | 2014-09-23 | Roche Diagnostics Operations, Inc. | Methods and systems for processing glucose data measured from a person having diabetes |
| US8579879B2 (en) | 2010-02-19 | 2013-11-12 | Medtronic Minimed, Inc. | Closed-loop glucose control startup |
| US8532933B2 (en) | 2010-06-18 | 2013-09-10 | Roche Diagnostics Operations, Inc. | Insulin optimization systems and testing methods with adjusted exit criterion accounting for system noise associated with biomarkers |
| US8589106B2 (en) | 2010-12-22 | 2013-11-19 | Roche Diagnostics Operations, Inc. | Calibration of a handheld diabetes managing device that receives data from a continuous glucose monitor |
| US8774889B2 (en) | 2010-12-22 | 2014-07-08 | Roche Diagnostics Operations, Inc. | Patient monitoring system with efficient pattern matching algorithm |
| US20140088392A1 (en) | 2011-02-11 | 2014-03-27 | Abbott Diabetes Care Inc. | Feedback from Cloud or HCP to Payer or Patient via Meter or Cell Phone |
| GB2493712B (en) * | 2011-08-12 | 2014-07-02 | Gene Onyx Ltd | Insulin pump |
| CA3175850A1 (en) | 2011-08-26 | 2013-03-07 | Stephen D. Patek | Method, system and computer readable medium for adaptive advisory control of diabetes |
| US10881339B2 (en) | 2012-06-29 | 2021-01-05 | Dexcom, Inc. | Use of sensor redundancy to detect sensor failures |
| US9364609B2 (en) * | 2012-08-30 | 2016-06-14 | Medtronic Minimed, Inc. | Insulin on board compensation for a closed-loop insulin infusion system |
| US9623179B2 (en) | 2012-08-30 | 2017-04-18 | Medtronic Minimed, Inc. | Safeguarding techniques for a closed-loop insulin infusion system |
| US9504412B2 (en) | 2012-09-17 | 2016-11-29 | Lifescan, Inc. | Method and system to derive glycemic patterns from clustering of glucose data |
| US9592002B2 (en) | 2012-09-21 | 2017-03-14 | Lifescan, Inc. | Method and system to derive multiple glycemic patterns from glucose measurements during time of the day |
| US10463282B2 (en) | 2012-10-04 | 2019-11-05 | Roche Diabetes Care, Inc. | System and method for assessing risk associated with a glucose state |
| US9119528B2 (en) | 2012-10-30 | 2015-09-01 | Dexcom, Inc. | Systems and methods for providing sensitive and specific alarms |
| US9486578B2 (en) * | 2012-12-07 | 2016-11-08 | Animas Corporation | Method and system for tuning a closed-loop controller for an artificial pancreas |
| US10383580B2 (en) | 2012-12-31 | 2019-08-20 | Abbott Diabetes Care Inc. | Analysis of glucose median, variability, and hypoglycemia risk for therapy guidance |
| US9351670B2 (en) | 2012-12-31 | 2016-05-31 | Abbott Diabetes Care Inc. | Glycemic risk determination based on variability of glucose levels |
| US9227014B2 (en) | 2013-02-07 | 2016-01-05 | The Board Of Trustees Of The Laland Stanford Junior University | Kalman filter based on-off switch for insulin pump |
| CN105899127B (zh) | 2013-11-14 | 2019-09-24 | 加州大学董事会 | 血糖率上升检测器:用于健康监测系统的膳食检测模块 |
| US10722650B2 (en) | 2014-03-28 | 2020-07-28 | Roche Diabetes Care, Inc. | System and method for adjusting therapy based on risk associated with a glucose state |
| US9465917B2 (en) | 2014-05-30 | 2016-10-11 | Roche Diabetes Care, Inc. | Hazard based assessment patterns |
| RU2014135270A (ru) * | 2014-08-29 | 2016-03-20 | Государственное бюджетное образовательное учреждение дополнительного профессионального образования "Российская медицинская академия последипломного образования" Министерства здравоохранения Российской Федерации (ГБОУ ДПО РМАПО Минздрава России) | Способ оценки эффективности и безопасности сахароснижающей терапии у больных сахарным диабетом с сердечно-сосудистыми заболеваниями |
-
2016
- 2016-06-01 US US15/170,425 patent/US10332632B2/en active Active
-
2017
- 2017-05-09 AU AU2017275393A patent/AU2017275393B2/en active Active
- 2017-05-09 KR KR1020187037674A patent/KR102432415B1/ko active Active
- 2017-05-09 HU HUE17725003A patent/HUE061267T2/hu unknown
- 2017-05-09 ES ES17725003T patent/ES2939640T3/es active Active
- 2017-05-09 CA CA3025902A patent/CA3025902C/en active Active
- 2017-05-09 MX MX2018014683A patent/MX394631B/es unknown
- 2017-05-09 EP EP17725003.2A patent/EP3479262B1/en active Active
- 2017-05-09 WO PCT/US2017/031662 patent/WO2017209903A1/en not_active Ceased
- 2017-05-09 FI FIEP17725003.2T patent/FI3479262T3/fi active
- 2017-05-09 CN CN201780048458.6A patent/CN109478422B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| KR102432415B1 (ko) | 2022-08-12 |
| CA3025902C (en) | 2024-06-11 |
| CN109478422B (zh) | 2022-05-24 |
| US20170348482A1 (en) | 2017-12-07 |
| EP3479262B1 (en) | 2023-01-11 |
| BR112018074909A2 (pt) | 2019-03-12 |
| KR20190013922A (ko) | 2019-02-11 |
| AU2017275393B2 (en) | 2022-03-17 |
| FI3479262T3 (fi) | 2023-03-23 |
| MX2018014683A (es) | 2019-02-28 |
| EP3479262A1 (en) | 2019-05-08 |
| CA3025902A1 (en) | 2017-12-07 |
| WO2017209903A1 (en) | 2017-12-07 |
| HUE061267T2 (hu) | 2023-06-28 |
| CN109478422A (zh) | 2019-03-15 |
| ES2939640T3 (es) | 2023-04-25 |
| AU2017275393A1 (en) | 2019-01-03 |
| WO2017209903A8 (en) | 2018-08-30 |
| BR112018074909A8 (pt) | 2023-01-31 |
| US10332632B2 (en) | 2019-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2018014683A (es) | Protecciones contra fallas de control a intervalo. | |
| CY1124983T1 (el) | Επιθετικοτητα ελεγχου εντος διαστηματος | |
| WO2019140441A3 (en) | Wound sensor and diagnostics system for wound therapy applications | |
| MX392755B (es) | Sistema de monitoreo de paciente. | |
| CY1125434T1 (el) | Mεθοδος για τη μετρηση των χαρακτηριστικων ροης σε εναν εισπνευστηρα, εισπνευστηρας και συστημα | |
| BR112018002219A2 (pt) | sistema para monitorar sinais vitais | |
| WO2010147659A3 (en) | Closed-loop glucose and/or insulin control system | |
| EP4406591A3 (en) | Medical device operational modes | |
| NZ710327A (en) | Infusion pump and method to enhance long term medication delivery accuracy | |
| EP4541392A3 (en) | Sensor device removably attachable to a drug delivery device | |
| WO2017006313A3 (en) | Apparatus, system and method for pain monitoring | |
| MX2016006252A (es) | Tratamiento o prevencion de afecciones pulmonares con monoxido de carbono. | |
| WO2014144604A3 (en) | Contextual heart rate monitoring | |
| MX2020003343A (es) | Sistema de validacion de sensor en-linea. | |
| EP4324921A3 (en) | Biointerface layer for analyte sensors | |
| EP4420603A3 (en) | System and method to manage diabetes based on glucose median, glucose variability, and hypoglycemic risk | |
| MX2020010710A (es) | Sistema y metodo para detectar proliferacion de biopelicula en sistemas hidricos. | |
| ATE493063T1 (de) | Implantierbares gewebeperfusions-messsystem und verfahren | |
| BR112012016773A2 (pt) | "sistema de controle para um sistema de segurança que inclui uma pluralidade de sensores, sistema de segurança,e, método para monitorar uma localização." | |
| WO2016176301A3 (en) | System for integrating multiple sensor data to predict a fall risk | |
| PH12013501434A1 (en) | Apparatuses and methods for diagnosing swallowing dysfunction | |
| MX2020001276A (es) | Sistemas y metodos de control de glucosa en sangre de circuito cerrado. | |
| MX2016005127A (es) | Aparato sensor y metodo para monitorear un signo vital de un individuo. | |
| GB2543203A (en) | Downhole thermal anomaly detection for passive ranging to a target wellbore | |
| WO2015150069A8 (en) | Method and device for the non-invasive monitoring and identification of drug effects and interactions |